Lung Cancer Considered

The latest episode of Lung Cancer Considered discusses biological and molecular staging as a dimension beyond sized-based staging. This episode features a conversation between host Dr. Jack West and Dr. Daniel Boffa, professor and division chief of thoracic surgery at Yale University.

The latest episode of “Lung Cancer Considered” discusses the practice patterns and clinical trials in India and how COVID-19 has impacted the field in India. This episode features a conversation between host Dr. Jack West and Dr. Vanita Noronha, professor of medical oncology at Tata Memorial Hospital, Mumbai, India.

The latest episode of Lung Cancer Considered brings you part two of our conversation on lung cancer stigma during Lung Cancer Awareness Month. This episode features a discussion with Jill Feldman, patient advocate; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a professor in the division of medical oncology, department of medicine at the University of Colorado School of Medicine; and Mary Pasquinelli, a nurse practitioner in the Pulmonary Division at UI Health at the University of Illinois.

In the latest episode of Lung Cancer Considered, we kick off Lung Cancer Awareness Month focusing on stigma within the lung cancer community and what we can all do to understand and overcome it. This episode features a conversation between Jill Feldman, lung cancer patient advocate and co-founder of EGRF Resisters; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a professor in the Division of Medical Oncology, Department of Medicine at the University of Colorado School of Medicine; and Mary Pasquinelli, a nurse practitioner in the Pulmonary Division at UI Health at the University of Illinois.

The latest episode of Lung Cancer Considered focuses on the data and clinical outcomes for patients who may go off immunotherapy after two years. This episode features a conversation between host Dr. Jack West and Dr. Matt Hellman, associate attending at Memorial Sloan Kettering Cancer Center.

In the latest episode of Lung Cancer Considered, we're going back to October 2019, pre-COVID, when Dr. Jack West interviewed Dr. Tony Mok about highlights and new research from the 2019 IASLC World Conference on Lung Cancer. We’re feeling nostalgic about being able to meet in person and heartened by how far we’ve come since our last time together.

In the latest episode of Lung Cancer Considered, three experts in thoracic oncology from around the world discuss and share their stories and experience about diversity and equity in medicine. This episode features a conversation between Dr. Narjust Duma, assistant professor of medicine - thoracic oncology at the University of Wisconsin Carbone Cancer Center; Dr. Jhanelle Gray, chair of the department of thoracic oncology and program co-leader for chemical biology and molecular medicine at the Moffitt Cancer Center; and Dr. Clarissa Mathias, Brazilian Society of Medical Oncology president, IASLC Board Member, Chair of the ASCO International Committee and Medical Oncologist at Grupo Oncoclinicas.

The latest episode of Lung Cancer Considered focuses on using digital and social media connections as an educational tool given that COVID-19 has limited in-person interactions. This episode features a conversation between host Dr. Jack West and Dr. Sanjay Mukhopadhyay, director of Pulmonary Pathology at the Cleveland Clinic.

The latest episode of Lung Cancer Considered focuses on the upcoming IASLC Liquid Biopsy Meeting that will discuss the current status of liquid biopsy in the field of thoracic. This episode features a conversation between Dr. David Gandara, director of thoracic oncology, professor emeritus, and senior advisor to the director at the UC Davis Comprehensive Cancer Center; Dr. Maria Arcila, director of the diagnostic molecular pathology laboratory at Memorial Sloan Kettering Cancer Center; and Dr. Christian Rolfo, director of the thoracic medical oncology and early clinical trials at the University of Maryland Comprehensive Cancer Center (UMGCCC), a professor in the division of hematology-oncology at the University of Maryland, and educational chair of the International Society of Liquid Biopsies.

The latest episode of Lung Cancer Considered focuses on the IASLC Pathology Committee's creation of the Immunohistochemistry (IHC) Atlas. This episode features a conversation between host Dr. Sanja Dacic, a professor in the department of pathology at the University of Pittsburg Medical Center in Pennsylvania; Dr. Keith Kerr, professor of pulmonary pathology at Aberdeen University Medical School and a consultant pathologist at the Aberdeen Royal Infirmary in Scotland; and Dr. Yasushi Yatabe, chief of the department of diagnostic pathology at the National Cancer Center in Toyko, Japan.